AAHFN 2021 – Failure is Not an Option: Considering Cardiac Contractility Modulation Therapy for Your Heart Failure Patients

August 11, 2021

This video is a lecture from AAHFN Virtual Scientific Session titled CCM® Therapy – Device-Based Approach for the Treatment of Heart Failure. Lisa Rathman, NP and Marc Goldschmidt, MD have a clinical discussion about the complex decisions that are involved when managing a patient with heart failure from optimizing drug therapy to trying to provide a better quality of life for patients. Dr. Goldschmidt points out that optimizing medications is an extremely complex process and often requires multiple inputs.

  • October 26, 2021 - U.S. Food and Drug Administration approved a modification of labeling for the Optimizer® Smart medical device, allowing the removal of “normal sinus rhythm” (NSR) from the indications for use statement as of 10/26/2021. Please note that this presentation was done prior to this FDA update.
Login to view comments. Click here to Login